Best Treatment For Heartburn In Clearwater, FL

Two things changed on the medication side, and one widely repeated claim about surgery is still not true yet.

A new drug class arrived. Vonoprazan, sold as Voquezna, is the first potassium-competitive acid blocker approved in the United States. The FDA approved it on November 1, 2023 for healing erosive esophagitis, then on July 18, 2024 for heartburn relief in non-erosive GERD, which is the larger group. It works differently from a PPI: it does not need acid to activate, it starts working faster, it lasts longer, and it is taken once daily with or without food. The FDA’s own review documentation covers the trial data behind the approval. Most Clearwater pages ranking for heartburn either skip this entirely or mention it in passing.

A second one is under review. Sebela Pharmaceuticals filed a New Drug Application for tegoprazan on January 9, 2026, based on the Phase 3 TRIUMpH program in more than 2,000 US patients. Tegoprazan outperformed lansoprazole for healing erosive esophagitis at 2 and 8 weeks and for maintaining that healing at 24 weeks, including in the most severe grades. It is not approved. Ask about it, but do not plan around it.

Now the correction. RefluxStop is not available in the United States. It carries a CE mark in Europe and has multi-year outcome data there, but it remains under FDA premarket approval review. Implantica submitted its final response to the FDA’s remaining questions on May 20, 2026, following six pre-approval inspections. Several pages in this market describe RefluxStop as arriving in 2026 and count it as a fourth available procedure. It is not one yet. Dr. Grandhige intends to offer it when the FDA approves it, and until that happens this practice performs three anti-reflux procedures, not four.

None of this changes the underlying point. A better acid blocker is still an acid blocker. It will not repair a hiatal hernia.

If your symptoms are chronic throat clearing, hoarseness, cough, postnasal drip, ear pressure or a lump-in-the-throat sensation, standard reflux testing can come back normal and still be the wrong test.

Standard pH studies measure reflux above the lower esophageal sphincter. Laryngopharyngeal reflux, or silent reflux, happens higher, above the upper esophageal sphincter, in tissue that is far more sensitive than the esophagus. The scale of that difference matters: the esophagus can tolerate 40 to 50 reflux episodes a day, while the larynx and pharynx can become symptomatic from one episode a day. A study that only looks at the lower level will miss it.

Dr. Grandhige uses a customized 24-hour dual-channel pH impedance probe placed through the nose in the office. It measures at both levels, above the lower sphincter and above the upper sphincter, and because it includes impedance it captures non-acid reflux as well. That matters because bile, pepsin and trypsin reach the throat too, and a pH-only study cannot see them.

The clinical consequence is direct. LPR patients are commonly quoted around a 50 percent chance that surgery helps. With dual-level testing identifying who is actually refluxing into the pharynx, Dr. Grandhige reports symptom improvement in the range of 80 percent in the patients he selects. Roughly 50 to 60 percent of LPR patients who test end up with findings that justify a procedure. The other 40 to 50 percent are told no, which is the point of the test.

Two things patients should know before starting. This testing is technically demanding and reimbursed poorly, which is why most centers do not offer it. And LPR does not resolve on the timeline patients expect. Typical heartburn often stops the night of surgery. Throat symptoms generally take 4 to 6 months to improve.

Every anti-reflux procedure adds resistance at the gastroesophageal junction, and that resistance has a cost.

After a fundoplication, bloating and difficulty vomiting are the common complaints. Making it harder for acid to come up also makes it harder for air and food to come up. Whether that is temporary or permanent depends on the wrap type. After LINX, early swallowing difficulty is common and a small number of patients have longer-term dysphagia; recovery requires actively swallowing small bites hourly to keep the device working through the inflammatory phase. After TIF, some patients still need some acid suppression even when symptoms improve.

All three are functional operations. Like a joint replacement, they work well, they are subject to wear, and revision may be needed across a lifetime.

Some patients are told no, and it is a longer list than most practices publish. Untreated severe motility disorders. Reflux-like symptoms with no objective reflux on testing. Esophageal hypersensitivity, functional chest pain and rumination, all of which imitate reflux and none of which surgery improves. Obese patients seeking TIF. Dr. Grandhige is direct about the human cost of this: the patients he declines to operate on are often the unhappiest people leaving the office, and they would be far unhappier after an operation that did not fix anything.

The other honest limit is scope. Surgery corrects reflux. It does not correct every symptom you walked in with. Heartburn and regurgitation may resolve completely while throat symptoms improve partially and bloating persists from a separate mechanism. Dr. Grandhige states which symptoms he expects to improve, which may improve partially and which are unlikely to change, before anything is scheduled, and asks patients to give it six months before evaluating what remains.

Plan on 30 to 45 minutes each way, and send your records before you come.

Email prior studies to info@tampareflux.com ahead of the appointment: endoscopy and pathology reports, any pH testing including Bravo or catheter studies, manometry results, barium swallow or other imaging, office notes from your gastroenterologist, ENT, pulmonologist or allergist, a current medication list, and a list of prior surgeries. Studies from years ago are still useful for showing progression. Signed record releases get sent immediately, but fax systems and incompatible electronic records mean releases alone frequently arrive late or incomplete. Patients who bring their own records get a definitive visit instead of a preliminary one.

Dr. Grandhige reviews everything personally before you arrive, including how other physicians have interpreted your symptoms.

The timeline is structured deliberately. New patients are usually seen within 2 weeks and always within 4. If your testing is already complete, one consultation is typically enough and surgery can often be scheduled about 4 weeks out. If testing is needed, the first visit covers education and test planning, a second visit about 4 weeks later reviews results and finalizes the plan, and the target from first visit to surgery is roughly 8 weeks. Insurance authorization is handled entirely by the office, can take 4 to 6 weeks, and is always secured before surgery is scheduled.

All surgery is performed at HCA South Tampa Hospital. Dr. Grandhige used to operate at four area hospitals and deliberately consolidated to one, so the same anesthesia team, nurses and surgical technologists handle every case. His own employed physician assistant assists every operation, knows each patient’s specific anatomy, and handles postoperative questions. After hours, patients reach Dr. Grandhige directly. Several of the medical assistants have worked with him for over a decade.

On credentials: Dr. Grandhige completed a bachelor of science in biology at Johns Hopkins University, his medical degree at the University of Michigan, general surgery residency at Yale New Haven Hospital, and two fellowships there, one in burn and critical care and one in foregut and minimally invasive surgery. He is a board-certified general surgeon, a Fellow of the American College of Surgeons, a member of SAGES, and a founding member of the American Foregut Society. He has practiced in Tampa Bay since 2009 and founded the practice profiled on our about us page in 2022. Verify his license and disciplinary history yourself through the Florida Department of Health MQA search portal.

The office is in a yellow brick building at 1315 South Howard Avenue, Suite 101, next to Sally O’Neill’s Pizza, with parking behind the restaurant.